Due to BACE1′s critical role as the initiating enzyme in amyloid-beta production, it has been selected as a prime target for slowing the progression of Alzheimer’s disease by lowering amyloid-beta levels in the brain [56]. This evidence concerns the gene BACE1 and early-onset autosomal dominant Alzheimer disease.